Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (HERMeS): a multicentre, randomised controlled trial
Loading...
Identifiers
Publication date
Authors
Yun, Sergi
Comín Colet, J.
Calero Molina, Esther
Hidalgo, Encarnación
José Bazán, Núria
Advisors
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
SDG
Metrics
Abstract
he potential of mobile health (mHealth) technology combining telemonitoring and teleintervention as a non-invasive intervention to reduce the risk of cardiovascular events in patients with heart failure during the early post-discharge period (ie, the vulnerable phase) has not been evaluated to our knowledge. We investigated the efficacy of incorporating mHealth into routine heart failure management in vulnerable-phase patients.
Description
UNESCO Subjects
Keywords
Bibliographic reference
Yun, S., Comín-Colet, J., Calero-Molina, E., Hidalgo, E., José-Bazán, N., Cobo Marcos, M., Soria, T., Llàcer, P., Fernández, C., García-Pinilla, J. M., Cruzado, C., González-Franco, Á., García-Marina, E. M., Morales-Rull, J. L., Solé, C., García-Romero, E., Núñez, J., Civera, J., Fernández, C., … Fernández, J. (2025). Evaluation of mobile health technology combining telemonitoring and teleintervention versus usual care in vulnerable-phase heart failure management (Hermes): A multicentre, randomised controlled trial. The Lancet Digital Health, 7(5), 100866. https://doi.org/10.1016/j.landig.2025.02.006
Editor's version
http://doi.org/10.1016/j.landig.2025.02.006Type of document
Collections
La licencia de este ítem se describe como Attribution-NonCommercial-NoDerivatives 4.0 International